Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Improved Efficacy of a Dendritic Cell-Based Vaccine against a Murine Model of Colon Cancer: The Helper Protein Effect
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model
Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment
Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer
Perspectives for immunotherapy in glioblastoma treatment
Emerging treatment strategies for glioblastoma multiforme
Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm
Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression
Dendritic cell cancer vaccines: from the bench to the bedside
IOZK Fallstudie über die erfolgreiche Behandlung eines metastasierten Prostatakarzinoms
Overexpression of heat shock protein 27 (HSP27) increases gemcitabine sensitivity in pancreatic cancer cells through S-phase arrest and apoptosis
Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma
Inhibition of cell proliferation by mild hyperthermia at 43˚C with Paris Saponin I in the lung adenocarcinoma cell line PC-9
Apoptotic induction of lung adenocarcinoma A549 cells infected by recombinant RVG Newcastle disease virus (rL-RVG) in vitro
Hyperthermia, radiation and chemotherapy: the role of heat in multidisciplinary cancer care
Long-term remission of prostate cancer with extensive bone metastases upon immuno- and virotherapy: A case report
Strong T‑cell costimulation can reactivate tumor antigen‑specific T cells in late‑stage metastasized colorectal carcinoma patients: results from a phase Ⅰ clinical study
[The effect of immunotherapy and hyperthermia on patients with advanced or recurrent cancer – analyses by cancer type and recurrence form]
[The effect of immunotherapy and hyperthermia on advanced or recurrent ovarian and uterine cancer – 229 clinical cases]